Penetrium Bioscience Inc. Stock: price and insider trades · South Korea
페니트리움바이오
2 insiders bought €8.4M of shares over the last 90 days, the latest by 박차석, filed 19 Oct 2026.
Who traded when
BuySaleSince the insiders bought
- +39.6%Entry ₩4,370 · Close 30 Oct 2026 ₩6,100
- -33.9%Entry ₩3,405 · Close at T+365 ₩2,250
- -62.6%Entry ₩3,130 · Close at T+365 ₩1,172
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 10,000 sharesShareKRXDART:20261019000202Canonical exit: 17 Jan 2027 (T+90)
- Other0DART
- Other0DART
- Other0DART
- 2,233,264 sharesShareKRXDART:20260904000470Canonical exit: 3 Dec 2026 (T+90)
- Other0DART
- 10,000 sharesShareKRXDART:20260902000113Canonical exit: 1 Dec 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- ●Executives0DART
- 0KRXDART:20260326000917
- 0KRXDART:20260312001151
- 5,600 sharesShareKRXDART:20260210000752Canonical exit: 11 May 2026 (T+90)
- 850,831 sharesKRXDART:20251219000494Canonical exit: 16 Mar 2026 (T+90)
- 15,000 sharesShareKRXDART:20251212000551Canonical exit: 12 Mar 2026 (T+90)
- ●Executives0DART
- 1,146,226 sharesShareKRXDART:20251107000579Canonical exit: 5 Feb 2026 (T+90)
- 10,500 sharesShareKRXDART:20251029000397Canonical exit: 27 Jan 2026 (T+90)
- 2,524,260 sharesKRXDART:20251002000499
- ●Executives0DART
- ●Executives0DART
- 10,000 sharesShareKRXDART:20250807000225Canonical exit: 5 Nov 2025 (T+90)
- 11,369,530 sharesKRXDART:20250703000437Canonical exit: 24 Sept 2025 (T+90)
- 6,623,641 sharesShareKRXDART:20250703000432Canonical exit: 1 Oct 2025 (T+90)
25 of 53 declarations
About Penetrium Bioscience Inc.
Two entities concentrate the record of 페니트리움바이오 (Penetrium Bioscience Inc.): 모비스 files 22, including 12 sales and one purchase, and 현대바이오 (10%이상주주) 15, including 8 purchases. 박차석 (감사위원) signs 6 purchases, and 상상인저축은행 (대량보유자) one purchase and one sale. No amount is stated. In all, 16 purchases and 13 sales, or 55% purchases.
From September 2 to September 4, 2026, 2 distinct filers bought. The 46 filings were published from June 3, 2021 to October 19, 2026, with 16 in 2021, 4 in 2022, 8 in 2024, 11 in 2025 and 7 in 2026. For 17 filings, the item is neither a purchase nor a sale.
Read moreShow less
South Korean health care at KRW 374.0 billion, 32.2% of the capital with insiders, 5 filers. The 12 filings of the latest year include 8 purchases and no sale. Publication delay at the median: 7 days. The record has 5 filers and no trade is dated before March 2024.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
